Marketing-authorisation holder · United States
Eugia Pharma
19 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
19 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
19 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AMPHOTERICIN B50mg/vial · Injectable, liposomal | Amphotericin b | United States | Marketed | 2021 |
| ANASTROZOLE1MG · Tablet | Anastrozole | United States | Marketed | 2007 |
| BIVALIRUDIN250mg/vial · Injectable | Bivalirudin | United States | Marketed | 2015 |
| CARFILZOMIB10mg/vial | 30mg/vial | 60mg/vial · Powder | Carfilzomib | United States | Marketed | 2019 |
| CLOFARABINE20mg/20ml (1mg/ml) · Solution | Clofarabine | United States | Marketed | 2017 |
| ESOMEPRAZOLE SODIUM20mg base/vial | 40mg base/vial · Injectable | Esomeprazole | United States | Marketed | 2013 |
| EXEMESTANE25mg · Tablet | Exemestane | United States | Marketed | 2011 |
| GENTAMICIN SULFATE1.2mg base/ml | 1.4mg base/ml | 1.6mg base/ml | 1.8mg base/ml | 100mg base/100ml | 10mg base/ml | 2mg base/ml | 40mg base/ml | 60mg base/100ml | 70mg base/100ml | 80mg base/100ml | 90mg base/100ml · Injectable | Gentamicin | United States | Marketed | 1980 |
| HYDROXYPROGESTERONE CAPROATE1250mg/5ml (250mg/ml) · Solution | Hydroxyprogesterone caproate | United States | Not marketed | 2015 |
| LEUPROLIDE ACETATE14mg/2.8ml (1mg/0.2ml) · Solution | Leuprorelin | United States | Marketed | 1998 |
| MILRINONE LACTATE IN DEXTROSE 5%20mg base/100ml (eq 0.2mg base/ml) | 40mg base/200ml (eq 0.2mg base/ml) · Injectable | Milrinone | United States | Marketed | 2005 |
| MOXIFLOXACIN HYDROCHLORIDE0.5% base · Solution/drops | Moxifloxacin | United States | Marketed | 2014 |
| NEOSTIGMINE METHYLSULFATE10mg/10ml(1mg/ml) | 5mg/10ml(0.5mg/ml) · Injectable | Neostigmine | United States | Marketed | 2023 |
| OLANZAPINE10mg/vial · Powder | Olanzapine | United States | Marketed | 2011 |
| PANTOPRAZOLE SODIUM40mg base/vial · Injectable | Pantoprazole | United States | Marketed | 2012 |
| PIPERACILLIN AND TAZOBACTAM0.375g | 0.5g/1vial | 12gm base/vial | 3.0g | 36g | 36gm base/vial | 4.0g | 4.5g · Injection | Piperacillin, Tazobactam | United States | Marketed | 2023 |
| SILDENAFIL CITRATE10mg base/12.5ml (eq 0.8mg base/ml) · Solution | Sildenafil | United States | Marketed | 2015 |
| TAMOXIFEN CITRATE10mg base | 20mg base · Tablet | Tamoxifen | United States | Marketed | 2003 |
| TIGECYCLINE50mg/vial · Powder | Tigecycline | United States | Marketed | 2015 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 19 | 19 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.